China Kangtai Cactus Bio-Tech Inc (fka CKGT)

[pegasus1]

These private equity firms who work with OTC issues make me nervous. I work at an OTC listed company and the sales pitches and attempts to get restricted shares is relentless. Not to paint all of them with the same brush but quite a number of sales pitches from firms promoting their IR services like to produce stock charts of companies they have 'promoted', mostly through email, targeted phone calls (read boiler room). When you look at the stock charts, they are spikes. Straight up, and then straight down.

Not what a long-term strategy focused company should be looking for.

I hope CKGT hasn't fallen into that trap. Management has seemed more interested in executing their strategy than churning out press releases, which I kind of appreciate, to be perfectly honest.